ORION-8 A long term extension trial of the Phase III lipid-lowering
trials to assess the effect of long term dosing of inclisiran given as
subcutaneous injections in subjects with high cardiovascular risk
and elevated LDL-C
Please contact us for more information or to learn if you are eligible to participate.
